Aptahem AB (publ) (NGM:APTA)
0.6500
+0.0420 (6.91%)
At close: Jul 23, 2026
Aptahem AB Employees
Aptahem AB had 3 employees as of March 31, 2026. The number of employees decreased by 2 or -37.50% compared to the same quarter last year.
Employees
3
Change
-2
Growth
-37.50%
Revenue / Employee
839.36K SEK
Profits / Employee
-1.95M SEK
Market Cap
16.86M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 3 | -2 | -37.50% |
| Dec 31, 2025 | 3 | -1 | -25.00% |
| Sep 30, 2025 | 3 | -2 | -37.50% |
| Jun 30, 2025 | 3 | -3 | -50.00% |
| Mar 31, 2025 | 4 | -1 | -20.00% |
| Dec 31, 2024 | 4 | 0 | - |
| Sep 30, 2024 | 4 | -1 | -20.00% |
| Jun 30, 2024 | 5 | 0 | - |
| Mar 31, 2024 | 5 | -1 | -16.67% |
| Dec 31, 2023 | 4 | -1 | -20.00% |
| Sep 30, 2023 | 5 | -1 | -16.67% |
| Jun 30, 2023 | 5 | 0 | - |
| Mar 31, 2023 | 6 | 0 | - |
| Dec 31, 2022 | 5 | 1 | 25.00% |
| Sep 30, 2022 | 6 | 1 | 20.00% |
| Jun 30, 2022 | 5 | 0 | - |
| Mar 31, 2022 | 6 | 0 | 7.14% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 150 |
| ExpreS2ion Biotech Holding AB | 19 |
| 2cureX AB | 14 |
| Guard Therapeutics International AB | 12 |
| Fluicell AB | 11 |
| Ascelia Pharma AB | 10 |
| NanoEcho AB | 5 |
| Spago Nanomedical AB | 5 |
Aptahem AB News
- 2 months ago - Aptahem AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Aptahem AB Annual report: Q4 2025 - Filings
- 5 months ago - Aptahem AB Quarterly report: Q4 2025 - Filings
- 8 months ago - Aptahem AB Quarterly report: Q3 2025 - Filings
- 9 months ago - Aptahem AB Transcript: Status Update - Transcripts
- 9 months ago - Aptahem AB Press release: Status Update - Filings
- 10 months ago - Aptahem AB Press release: Status Update - Filings
- 11 months ago - Aptahem AB Quarterly report: Q2 2025 - Filings